Form 4 · Filed Jul 6, 2026, 09:11 PM UTC
LGND/LIGAND PHARMACEUTICALS INC
Espinoza Octavio — Chief Financial Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | J | other | 17 | $161 | $2,732 | 27,696 |
Source: SEC EDGAR raw filing ↗ · Accession 0002001011-26-000107